MediKarma, an AI-driven healthcare innovation company focused on preventive, value-based care, announced it has completed the acquisition of Nanell, a specialized digital pregnancy journey solution, from Niterra, a Japan-based industrial manufacturer. The deal integrates Nanell’s intellectual property, product assets, and operations into MediKarma’s platform, strengthening its Women’s Health capabilities and expanding its B2B2C footprint.
Nanell was created by Niterra Ventures Company to provide expert consultation, guided resources, and health tracking for expectant mothers. The solution has delivered targeted support for first-time and high-risk pregnancies and achieved retention rates above category averages. With this acquisition, MediKarma will embed Nanell’s pregnancy expertise directly into its unified patient profile, which consolidates EMR, claims, pharmacy, device, and patient-reported data to drive proactive care interventions.
Under the agreement, MediKarma acquires Nanell’s intellectual property and related assets, followed by a planned 60 to 90 day knowledge transfer and operational transition. The transaction includes equity-linked consideration and a revenue-share component tied to Nanell’s future growth. Niterra Ventures Company will provide transitional support as part of the arrangement.
The integration is designed to enhance MediKarma’s B2B2C strategy by delivering simpler, real-time guidance to members while enabling payors and employers to gain earlier risk visibility, improve contract performance, and reduce avoidable costs through a comprehensive longitudinal patient profile.
Founded as NGK Spark Plug Co., Ltd. in 1936 and rebranded as Niterra Co., Ltd., the company reported consolidated revenues of 652.9 billion yen, or 4,267 million USD, for fiscal 2024 ending March 2025. Niterra operates 31 bases in Japan and 62 overseas locations and employs approximately 16,000 people worldwide.
KEY QUOTES:
“This acquisition immediately fast-tracks MediKarma’s expansion into women’s health with a solution purpose-built for the critical moments that happen between visits,” “By integrating Nanell’s proven pregnancy expertise, we empower our members with clearer, real-time guidance and route meaningful signals back to care teams. This is a strategic move that strengthens value for payors and employers by offering earlier risk visibility and delivers a more human, proactive experience for families at a pivotal life stage.”
Kris Narayan, CEO, MediKarma
“Niterra Co., Ltd. invests and, in the past, also built ventures with the vision to improve everyone’s quality of life. Nanell was the result of researching women’s needs and building a solution for better support during pregnancy,” “We believe MediKarma’s platform is the perfect strategic home for Nanell’s next chapter. It connects specialized pregnancy insights to a longitudinal profile that ultimately benefits both members and care teams. We are excited to support MediKarma’s growth as it scales this unified capability across both B2B and B2C channels.”
Dirk Schapeler, President, Niterra Ventures Company of Niterra Co., Ltd.
